Forward mutation to 8-azagdanine resistance and reverse mutation to histidine prototrophy were measured in Salmonella typhimurium after treatment with 16 mutagens of both base-substitution and frameshift classes. The two approaches were found to be equisensitive for all 16 mutagensi.e., induction of significant mutation occurred at similar concentrations in the forward muation assay and in the most sensitive of the five Ames tester strains.
Rapid, inexpensive bacterial assays that measure chemically induced mutation are providing "early warning signals" of possible health hazards for humans. The most widely used system at present, that developed by Ames, detects reversion to histidine prototrophy in a set of Salmonella typhimurium strains (1) (2) (3) (4) (5) . In these assays, specific lesions in the histidine operon are backmutated or possibly suppressed to allow the bacterium to synthesize histidine. Several strains are used simultaneously in order to provide a variety of genetic lesions as targets because of the known specificity of certain chemical classes with regard to the kind of mutation induced and the sequence of DNA susceptible to mutation.
An alternative approach to reversion assays is a single forward mutation assay. In this type of assay the target for the mutagen can be an entire functional gene that codes for an enzyme that converts a nontoxic compound (selective agent) to a toxic metabolite. Loss of the enzyme by mutation results in resistance to the selective agent and thus provides a means of selecting for mutants in a treated population. In theory, forward assays would be sensitive to all base-pair substitutions and a large number of sequence-specific frameshift mutations. In practice, the forward assay must also be as sensitive quantitatively as a set of reversion assays-i.e., any proposed forward assay must respond to a wide variety of mutagens at concentrations equal to or less than those found to be mutagenic in the reversion assay. A number of investigators have examined bacterial forward mutation assays (6) (7) (8) . Ames and coworkers have compared several possible forward assays to the histidine reversion assays (cells were treated in agar) but found the forward assays deficient in terms of sensitivity (1, 2) .
Our group has developed a forward mutation assay in S. typhimurium based on resistance to-the purine analog 8-azaguanine (8-AG) (9 Bacterial Strains. S. typhimurium strains TA1535, TA1537, TA1538, TA98, and TA100 were the generous gifts of Bruce N. Ames (University of California, Berkeley, CA). Strain TM35 is a spontaneous his+ revertant of TA1535 (9) . Graham C. Walker (Department of Biology, Massachusetts Institute of Technology) provided strain TA2000 and instructed us in its use to create strain TM677, an isogenic derivative of TM35 that carries the "R-factor" plasmid pKM101, transferred from TA2000 by mating. TM677 was selected from the mated culture on a minimal agar plate containing 10,ug of ampicillin per ml. Cultures of the various strains possessing low spontaneous his+ backgrounds (TA1535, TA1537, TA1538, TA98, and TA100) and low spontaneous 8-AG-resistant backgrounds (TM35 and TM677) were selected and stored as 1-ml frozen aliquots as described (9 
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were placed in 25-cm2 plastic tissue flasks. Each flask then received 0.5 ml of sterile PMS, 2 units of glucose-6-phosphate dehydrogenase in 50 ,g of 5 mM citrate, and 0.5 ml of minimal E medium containing 5 mg of glucose 6-phosphate, 5 mg of NADP, and 3.33 mg of MgCl2. The flasks were incubated for 1 or 2 hr in a 370 dry-air incubator without shaking. After treatment, each culture was transferred to plastic centrifuge tubes, centrifuged, and resuspended in phosphatebuffered saline (Pi/NaCI) (NaCl, 8 .0 mg/ml; KCI, 0.2 mg/ml; Na2HPO4, 1.15 mg/ml; KH2PO4, 0.2 mg/ml; pH 7.0). Approximately 4 X 108 cells per dish were plated in triplicate on minimal E agar (minimal E medium containing 0.6% BactoAgar; pH 6.5) plates containing biotin and 8-AG (final concentration on plate; 50 ,tg/ml) to determine the 8-AG-resistant fraction. Also, approximately 400 cells per dish were plated in triplicate on minimal E agar plates containing biotin and no 8-AG, to determine toxicity. The plating procedure has been described (9) .
his+ Reversion Assay. Strains TA1535, TA1537, TA1538, TA98 and TA100 were used in these studies. Culture inoculation, growth, and treatment were similar to those described for the forward assay, except that cell density at the beginning of treatment was approximately 1 X 108/ml. S. typhimurium cultures of 107 or 108 bacteria per ml were in exponential growth phase, and no effect of cell density in this range on mutation has been observed. After treatment, the cells were centrifuged, washed in 5 ml of Pi/NaCl to ensure removal of all histidine, and resuspended in 0.5 ml of Pi/NaCl. A 0. 1-ml aliquot of the suspension was added to 0.9 ml of top agar (0.6% Bacto-Agar, 0.6% NaCl), and the resulting mixture was plated on a minimal E agar (minimal E medium, 0.6% Bacto-Agar, pH 7.0) plate with biotin and no histidine to determine the his+ revertant fraction. Also, a 0. 1-ml aliquot of a 10-6 dilution of the Pi/NaCl suspension was added to 0.9 ml of top agar, and the resulting mixture was plated on a minimal E agar plate containing biotin and 5 mM histidine to determine toxicity. Plating was performed in triplicate. The fraction of his+ revertants after treatment was calculated as follows: (Table 1 ) is used to define the minimal concentration (dashed line) to which a particular bacterial strain is sensitive.
his + revertant fraction no. clones on mutation plates X 10-6 no. clones on toxicity plates
RESULTS
The rate of mutation (spontaneous and induced) is much lower in reverse mutation than in forward mutation. To compare the sensitivities of the assays directly, we have determined by interpolation the minimal concentration of each test compound at which each strain would theoretically yield a significant mutagenic response. Table 1 records our observations of spontaneous mutant fractions for all strains. The mean spontaneous revertant mutant fractions ranged from a low of 2.4 X 10-8 for TA1538 to a high of 22 X 10-8 for TA100. The mean spontaneous forward mutant fraction was 1.7 X 10-5 for TM35 and 4.7 X 10-5 for TM677. The inclusion of PMS, cofactors, and dimethyl sulfoxide had no effect on these values. Variation about the mean ranged from a low for TA1535, for which the SD was about 55% of the mean, to a high for TA1538, for which the SD was approximately equal to the observed mean. Sufficient data are thus available to define the 99% confidence interval on the mean spontaneous mutant fraction observed for. each strain. Spuriously high background mutant fractions were observed in 13 of a series of 137 independent determinations over all strains. We are unable to account for these occasional observations in terms of experimental practice. Our tentative conclusion is that they arise from an operational bias (cryptic contamination, growth as clumps prior to storing as aliquots, or some other cause) and not from random error. Thus, we have not included these results in the calculations of parameters reported in Table 1 Fig. 1 Fig. 1 Blanks indicate strains not sensitive at the highest concentration tested (see Table 2 ). * See Table 2 for additional abbreviations. Table 2 records the induced mutant fractions observed with each strain for all 16 compounds tested. Using this data and applying the process of Fig. 1 , we calculated the minimal concentration of each compound to which each strain is sensitive (Table 3 ). Table 3 separates the test compounds into three groups, based on their ability to revert strain TA1535 (base-substitution mutagens) and strains TA1537 or TA1538 (frameshift mutagens) at the concentrations tested. The known alkylating agents diethyl sulfate, dimethylnitrosoamine, MNNG, fl-propiolactone, and ethyl methanesulfonate exhibit specificity for reverting TA1535 and not TA1537 or TA1538. But three alkylating agents, dimethyl sulfate, methyl methanesulfonate, and methylnitrosourethane exhibit ability to revert both strains TA1535 and TA1537. Aflatoxin B1 mutates TA1535. AAF, 9-AA, 1,2,3,4-dibenzanthracene, 7,12-dimethylbenzanthracene, , and proflavin revert TA1537 or TA1538 but not TA1535 in the range of concentrations tested.
DISCUSSION
The addition of the plasmid pKM101 to strain TA1535, creating strain TA100, increases the sensitivity of the assay for two agents, diethyl sulfate and aflatoxin B1, but decreases sensitivity to dimethylnitrosamine, methylnitrosourethane, ,B-propiolactone, and MNNG. However, the change in sensitivity is no greater than 6-fold in any case. Adding the plasmid to TA1535 does, however, render it sensitive to frameshift mutagens such that TA100 is found to be the most sensitive reversion strain for proflavin and shows sensitivity to all compounds of this class. However, strain TA1537 responds to compounds such as 7,12-dimethylbenzanthracene and ICR-191, and TA98 responds to AAF, at concentrations much lower than does TA100, emphasizing the need for the use of several strains in screening protocols based on reversion assays.
Among those compounds reverting TA1538, addition of the plasmid to create strain TA98 increased sensitivity to 9-AA and somewhat to AAF but decreased sensitivity to ICR-191 and proflavin. The compounds active as mutagens at similar concentrations in both TA1535 and TA1537 or TA1538 present problems of analysis beyond the scope of this discussion. Table 3 also permits a quantitative comparison of the sensitivity of the most sensitive of the five reversion strains to the strains used in forward mutation assays. The plasmid pKM101 confers significant sensitivity to the forward assay among the frameshift mutagens. Although some actual diminution of sensitivity of the forward assay does occur with plasmid addition (e.g., (3-propiolactone) , the quantitative diminution is generally less than 2-fold. Thus, the sensitivity of one strain, TM677, in a forward mutation assay of each chemical may be compared to the most sensitive of the reversion assays.
In this comparison, some limits must be chosen to decide if a difference in sensitivity is (i) statistically significant and (ii) important in the bioassay of unknown chemicals. Roughly speaking, a 2-fold difference in the lowest concentration indicates a statistically significant observation, but ii is a matter of judgment. We suggest that differences in sensitivity within a 4-fold concentration range may not be important in actual practice.
By this arbitrary 4-fold limit, forward mutation assays with strain TM677 alone are found to be equisensitive with the set of five reversion assays for all 16 compounds tested.
Our conclusion is that the combination of Ames' physiological mutants (2) with this simple forward mutation assay in S. typhimurium (9) provides an improved means to perform quantitative assays of chemomutagenic potential. We should note that the studies by Ames and his colleagues (1,2) and others (6) (7) (8) have encompassed the idea of forward mutation assay in bacteria as a bioassay. However, in distinction to 8-AG resistance, measurement of mutation to azetidine carboxylic acid resistance was reported to be relatively insensitive when compared to reversion to histidine prototrophy (1, 2) . This lack of agreement may arise from complex differences between suspension-treated cells and cells treated in agar.
We have not yet discovered any chemical that is active in the forward assay but inactive in the Ames reversion assays. This fact renders questionable any hypotheses emphasizing the relative importance of the DNA sequence in limiting the general applicability of reversion assays for detecting mutagens (9) . On the other hand, the virtual equisensitivity of the forward assay and reversion assays raises some interesting questions about the molecular basis of mutation. The genetic target for forward mutation may mutate spontaneously at a number of different loci within a gene. It seems reasonable to assume that the molecular target for reversion is, in comparison, limited to a short nucleotide sequence. In the presence of a specific mutagenic stimulus that is highly active for a particular reversion site (e.g., 9-AA and TA1537; see Table 3 ), it would seem probable that the reversion assay would be much more sensitive than a forward mutation assay because of its apparently favorable signal-to-noise ratio. The fact that this is demonstrably not the case requires us to rethink some of our ideas about the chemomutagenic process.
In terms of bioassay practice, the ability to use one strain instead of five strains of S. typhimurium has obvious advantages. Of particular interest to us are the characteristics of forward mutation assay that permit automation of the process. It should also be noted that forward assays can be performed with exponentially growing cultures (108 cells per ml) in volumes as low as 10-100 tl. Small volumes spare the cost of expensive cofactors in large-scale bioassays and, in experimental practice, dramatically decrease the amount of compound required.
